KANGO SUJAY 4
4 · INFINITY PHARMACEUTICALS, INC. · Filed Mar 31, 2022
Insider Transaction Report
Form 4
KANGO SUJAY
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2022-03-30+90,000→ 90,000 totalExercise: $1.13Exp: 2032-03-29→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]The option vests as to 1/8th of the total number of shares on March 31, 2022 and as to 1/8th of the total number of shares at the end of each calendar quarter thereafter, provided that the Reporting Person continues to serve as a Director of the Issuer.